0001179110-13-013747.txt : 20130903
0001179110-13-013747.hdr.sgml : 20130902
20130903180726
ACCESSION NUMBER: 0001179110-13-013747
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130829
FILED AS OF DATE: 20130903
DATE AS OF CHANGE: 20130903
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Actavis, Inc.
CENTRAL INDEX KEY: 0000884629
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 953872914
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: MORRIS CORPORATE CENTER III
STREET 2: 400 INTERPACE PARKWAY
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
BUSINESS PHONE: 9092701400
MAIL ADDRESS:
STREET 1: MORRIS CORPORATE CENTER III
STREET 2: 400 INTERPACE PARKWAY
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
FORMER COMPANY:
FORMER CONFORMED NAME: WATSON PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930513
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BUCHEN DAVID A
CENTRAL INDEX KEY: 0001241751
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-13305
FILM NUMBER: 131076170
4
1
edgar.xml
FORM 4 -
X0306
4
2013-08-29
0
0000884629
Actavis, Inc.
ACT
0001241751
BUCHEN DAVID A
MORRIS CORPORATE CENTER III
400 INTERPACE PKWY
PARSIPPANY
NJ
07054
0
1
0
0
Chief Legal Officer-Global&Sec
Common Stock, par value $0.0033
2013-08-29
4
M
0
5000
35.11
A
102373
D
Common Stock, par value $0.0033
2013-08-29
4
M
0
5000
25.64
A
107373
D
Common Stock, par value $0.0033
2013-08-29
4
S
0
10000
135.5579
D
97373
D
Options to Purchase Common Stock
35.11
2013-08-29
4
M
0
5000
0
D
2015-08-12
Common Stock, par value $0.0033
5000
0
D
Options to Purchase Common Stock
25.64
2013-08-29
4
M
0
5000
0
D
2016-09-01
Common Stock, par value $0.0033
5000
0
D
Includes shares of restricted stock issued pursuant to the Fourth Amendment and Restatement of the 2001 Incentive Award Plan of Actavis, Inc., as amended
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $135.50 to $135.79, inclusive. The reporting person undertakes to provide to Actavis, Inc., any security holder of Actavis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.
Vested in four equal annual installments commencing on August 12, 2006.
Vested in four equal annual installments commencing on September 1, 2007.
/s/DAVID A. BUCHEN
2013-09-03